14-day Premium Trial Subscription Sign Up For FreeGet Free

Advaxis Stock Forecast NASDAQ:ADXS

Price Target and Analyst Ratings

Most Recent Rating

Alliance Global Partners is very positive about ADXS and gave it a "Buy" rating on April 19, 2021. The price target was changed from $5.00 to $2.25.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-04-19 Buy Target Lowered by Alliance Global Partners $0.46 $5.00 → $2.25

ADXS Stock Trend

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 3.23% during the next 3 months and, with a 90% probability hold a price between $0.41 and $0.62 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-22 $0.39 $0.50 $0.60
2021-09-23 $0.39 $0.50 $0.60
2021-09-24 $0.39 $0.50 $0.60
2021-09-27 $0.39 $0.50 $0.60
2021-09-28 $0.39 $0.50 $0.60
2021-09-29 $0.39 $0.50 $0.60
2021-09-30 $0.39 $0.50 $0.60
2021-10-01 $0.40 $0.50 $0.60
2021-10-04 $0.40 $0.50 $0.60
2021-10-05 $0.40 $0.50 $0.60
2021-10-06 $0.40 $0.50 $0.61
2021-10-07 $0.40 $0.50 $0.61
2021-10-08 $0.40 $0.50 $0.61
2021-10-11 $0.40 $0.50 $0.61
2021-10-12 $0.40 $0.50 $0.61
2021-10-13 $0.40 $0.50 $0.61
2021-10-14 $0.40 $0.50 $0.61
2021-10-15 $0.40 $0.50 $0.61
2021-10-18 $0.40 $0.50 $0.61
2021-10-19 $0.40 $0.50 $0.61
2021-10-20 $0.40 $0.50 $0.61
2021-10-21 $0.40 $0.50 $0.61
2021-10-22 $0.40 $0.50 $0.61
2021-10-25 $0.40 $0.50 $0.61
2021-10-26 $0.40 $0.50 $0.61
2021-10-27 $0.40 $0.51 $0.61
2021-10-28 $0.40 $0.51 $0.61
2021-10-29 $0.40 $0.51 $0.61
2021-11-01 $0.40 $0.51 $0.61
2021-11-02 $0.40 $0.51 $0.61

About Advaxis

Advaxis Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. Its lead product Axalimogene filolisbac (ADXS-HPV), an Lm-LLO immunotherapy product candidate, which completed its Phase II study used for the treatment of human papilloma virus (HPV) associated cancers, including cervical, head and neck, and anal cancer. The company is also dev... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT